#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma recurrent Squamous cell carcinoma of the cervix Prophylaxis against transplant rejection Vulval cancer recurrent Epstein-Barr virus associated lymphoproliferative disorder Immune-mediated myositis Cutaneous calcification Skin angiosarcoma Colorectal adenocarcinoma Salivary gland cancer Carcinoid tumour Selective polysaccharide antibody deficiency Small intestine adenocarcinoma Diffuse large B-cell lymphoma Small for dates baby More trials…

    Learn about Rare Diseases

    Epidermolysis bullosa – Treatment Small intestine leiomyosarcoma – Treatment Glomerulonephritis rapidly progressive – Diagnostics Systemic mastocytosis – Treatment Hereditary angioedema – Basic Information Haemophilia A without inhibitors – Diagnostics Hereditary optic atrophy – Basic Information Hypereosinophilic syndrome Mastocytosis Hereditary neuropathic amyloidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bms-986449-03 Carvedilol E2814 Fasudil Hydrochloride Citicoline Sodium Atorvastatin Calcium Cl-Ad-Msc-002 Cetirizine Stro-002 MB-HUCART19.1 Ipn01194 Albumin Dinoprostone Evolocumab BMS-986365 Epinephrine Bitartrate Guanabenz Acetate Lisdexamfetamine Dimesylate Bi-1910 Sodium Chloride Solution 0.9% More therapies…

    Learn about Your Condition

    End stage renal disease Breast proliferative changes Cachexia Endometrial cancer recurrent Psychotic disorder Leiomyosarcoma metastatic Hypertrophic cardiomyopathy Hip arthroplasty Erythema Ventricular extrasystoles Rubella Nasal sinus cancer Hepatorenal syndrome Altered state of consciousness Merycism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Muewxi Zypbanyf Knrmp 2bn Dezgnnbcv 4orxj Hvabxdb

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone
    • Leflunomide
    • Hydroxychloroquine Sulfate
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13
  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Other Analgesics And Antipyretics
    • Secukinumab
    Denmark Greece Hungary Italy Poland Spain
  • Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine with aura
    • Migraine without aura
    • Migraine
    Investigated Drugs:
    • Topiramate
    • Atogepant
    Austria Belgium Czechia France Germany Hungary +3
  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Magnetic resonance imaging
    • Nervous system disorder
    Investigated Drugs:
    • Gadoquatrane
    • Gadoteridol
    • Gadobutrol
    Bulgaria Czechia France Germany Hungary Italy +1
  • Study Comparing ARV-471 and Palbociclib with Letrozole and Palbociclib for Patients with Estrogen Receptor Positive, HER2-Negative Advanced Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
    • Palbociclib
    Hungary Italy Slovakia Spain
  • Study of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium France Germany Hungary Italy +4
  • Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fluocinolone Acetonide
    • Triamcinolone
    • Pimecrolimus
    Austria Belgium Bulgaria Croatia Czechia Finland +12
  • Study on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema

    Not recruiting

    4 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Dexamethasone
    Hungary Spain
  • Safety Study of Efgartigimod in Adults with Primary Sjögren’s Syndrome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Hungary Poland
  • Study of MK-0616 for Adults with Familial Hypercholesterolemia

    Not recruiting

    3 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Enlicitide Chloride
    Czechia Finland Hungary The Netherlands Norway Spain
Previous Page
1 … 40 41 42 43 44 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!